chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: Cold symptoms for 2-3 weeks; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Jun2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and fluoxetine hydrochloride (PROZAC). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Jun2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 23Jun2021, the patient experienced cold symptoms for 2-3 weeks. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event cold symptoms was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Vision blurred
Clinical narrative: High blood sugar; Dry eyes; Blur vision; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the left arm on 15Jun2021 at 10:00(at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, blood pressure high, chronic pain and legally blind. The patient did not receive any concomitant medications. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 04:00, the patient experienced blur vision and could have needed a new transplant in left eye, was waiting for follow up visit appointment soon. The patient also experienced high blood sugar, was waiting on call back from doctor and dry eyes. On 18Jun2021, the patient underwent blood glucose test and the result was blood sugar increased. Therapeutic measures were not taken as a result of adverse events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blur vision, high blood sugar and dry eye was unknown at  the time of this report.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Magnetic resonance imaging, Migraine, Vision blurred
Clinical narrative: Migraines; Eyesight since migraine gotten blurry; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 adverse event self-reporting method.  A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 26Feb2021 at 15:00 (at the age of 47-year-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm right on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history included migraine from an unknown date and the patient stated that she had migraines her whole life. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified concomitant medications.  The patient experienced migraines and eyesight since migraine gotten blurry from 05Jun2021 at 08:00. Details were as follows: on 05Jun2021 at 08:00, she started with migraines and had continued daily pounding to, at the time of this report (12Jul2021) and her eyesight since migraine gotten blurry. On an unknown date, the patient had an MRI (magnetic resonance imaging), CT (computed tomography) scan (results unspecified). She had been to the neurologist, pain doctor, chiropractor, holistic doctor, eye doctor (because her eyesight since this migraine had gotten blurry) and they could not find anything. The patient explained that no medication would help her with the pain which was odd, as when she normally would get a migraine, something would help. The patient stated, nothing had helped. The only change in her life had been the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. Since the vaccination, the patient has not been tested for COVID-19. The clinical outcome of migraines and eyesight since migraine gotten blurry was not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Knee joint pain. Started about a week after my second shot and has gotten progressively worse.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and depression. The patient has known allergy to penicillin (reported as possible penicillan). Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), fluticasone propionate, salmeterol xinafoate (ADVAIR), lamotrigine (LAMICTAL), salbutamol (VENTOLIN) and fluoxetine hydrochloride (PROZAC) all for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 17:00 the patient experienced knee joint pain which started about a week after the second shot and has gotten progressively worse. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event knee joint pain which started about a week after the second shot and has gotten progressively worse was not recovered at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: A few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169), via an unspecified route of administration on 01Jun2021 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. It was unknown whether the patient receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 29Apr2021 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. On 05Jun2021, the patient experienced "a few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month". The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of event which included treatment for vertigo but it did not solve. On 07May2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. The clinical outcome of the event "a few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month" was not resolved at the time of reporting.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Visual impairment
Clinical narrative: Shingles on my cornea on my right eye - vision impaired; Shingles on my cornea on my right eye - vision impaired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 29Apr2021 at 14:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021, the patient experienced shingles on her cornea on her right eye - vision impaired. The events resulted in doctor or other healthcare professional office/clinic visit. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of shingles on her cornea on her right eye - vision impaired and included treatment with Eye drops and oral medication. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events shingles on her cornea on her right eye - vision impaired was not resolved at the time of this report.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Computerised tomogram, Nausea, Vomiting
Clinical narrative: upper abdominal pain; consistent vomiting and nausea; consistent vomiting and nausea; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Reporting System. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 (also reported as dose 2)  via an unspecified route of administration, administered in arm left on 09Mar2021 (at the age of 52-years; Lot Number: EN6206) (also reported as: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included alpha 1 antitrypsin deficiency and psoriasis. Concomitant medications included adalimumab (HUMIRA); escitalopram oxalate (LEXAPRO). The patient previously took cefalexin monohydrate (KEFLEX) and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. On 28Apr2021 08:00, the patient experienced sudden onset of upper abdominal pain followed by consistent vomiting and nausea for 5 days. The second episode with exact same symptoms occurred approximately 2 months after the vaccine was administered. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as the result of the events which included IV (unspecified, for clarification), Zofran, CT scan (unknown results). The outcome of the events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Mucous stools, Nausea, SARS-CoV-2 test
Clinical narrative: Bloating; Nausea; Mucus in stool; Abdominal issues since the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 29Mar2021 at 15:45 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included nephrotic syndrome (remission), allergy to tree nuts and liquid latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified birth control medication within two weeks of vaccination. On 26Apr2021, the patient experienced abdominal issues since the vaccine, bloating, nausea and mucus in stool. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. On 11Jul2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events abdominal issues since the vaccine, bloating, nausea and mucus in stool were not resolved at the time of this report.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large hard swollen lymph nodes in neck primarily on the left side; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 05May2021 at 16:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), spironolactone (SPIROLACTON) and valaciclovir hydrochloride (VALTREX). The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. On 25May2021, the patient experienced large hard swollen lymph nodes in neck primarily on the left side .The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen lymph nodes was unknown at the time of this report.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Paraesthesia
Clinical narrative: tingling all throughout body after vaccination of first dose.; started having muscle spasms after receiving shot, , some are bigger spasms and others are smaller. but happening quiet constantly. still having spasms24 hours after vaccination.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy (bananas, avocados, apples), allergic to cats, adhesive tape allergy (some type of adhesive). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. On an unknown date in 2021, the patient experienced tingling all throughout body after vaccination of first dose, started having muscle spasms after receiving shot, some were bigger spasms and others were smaller. But happened quiet constantly, still had spasms 24 hours after vaccination. The patient did not receive any treatment for the events. The clinical outcome of the events tingling all throughout body, muscle spasms after receiving shot, some were bigger spasms and others were smaller. But happened quiet constantly was not recovered at the of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: had a rash all over; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. It was unknown if the patient had received any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient had a rash all over. It was unknown if therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the event, rash all over was unknown at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Dark rash multiple places on chest and arms; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0181) via an unspecified route of administration on 18Jun2021(at the age of 48-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Jul2021 at 16:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Jun2021, the patient experienced dark rash multiple places on chest and arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dark rash multiple places on chest and arms was not recovered at the time this report.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Worst headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 10Jul2021 at 16:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from unknown date for unknown indication. The patient had no allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0196), via an unspecified route of administration in the right arm on 19Jun2021 at 04:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 10Jul2021 at 17:30, the patient experienced worst headache she had in life, at the base of her head and behind her forehead. It was accompanied by nausea and had been consistent for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events worst headache and nausea were not resolved at the time of this report.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Visual impairment
Clinical narrative: Left eye twitching; Left eye vision problems; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: QW0177) via an unspecified route of administration in the left arm on 12Jun2021 at 10:00 (at the age of 53-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 06Jul2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, blood pressure high (high BP), depression, anxiety and neuropathy. The patient received unspecified concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took methotrexate (MANUFACTURER UNKNOWN) for psoriatic arthritis (discontinued for 2 weeks after both doses), INDERAL LA and hydralazine (MANUFACTURER UNKNOWN) for blood pressure high (high BP), WELLBUTRIN and ABILIFY for depression and anxiety, gabapentin (MANUFACTURER UNKNOWN) for neuropathy all were taken from unknown dates and unknown if ongoing. On 13Jun2021 at 12:00, the patient experienced left eye twitching and left eye vision problems after receiving first and second dose, problem went after two weeks on first dose, still experiencing symptoms since receiving second dose on 06Jul2021(as reported). The adverse events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events left eye twitching and left eye vision problems was recovering at the time of this report.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Heart aches and pains; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE), dose 1 at vaccination age of 43-year-old via an unspecified route of administration in the left arm on 24Apr2021 13:00 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included heart disease family history. The patient was not diagnosed with covid prior vaccination. The patient has no known allergies. There were no concomitant medications. The patient received the vaccine in a public health clinic. The patient did not receive other vaccine in four weeks. On 30Apr2021, the patient had heart aches and pains, and shortness of breath started within 2 weeks after her first dose at a public facility. The patient did not received treatment for the adverse event. The patient had a nasal swab on an unspecified date with negative results. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Flatulence, Injection site muscle weakness, Irritable bowel syndrome
Clinical narrative: Instant and massive IBS attack 30 seconds after injection; Bloating; discomfort and pain from gas pressure in stomach; discomfort and pain from gas pressure in stomach; Weakness is constant in left arm at injection point.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the left arm on 02Jun2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included GERD, irritable bowel syndrome (IBS) and cholinergic urticaria. The patient was allergic to sulfa drugs. Concomitant medications included famotidine (PEPCID), fexofenadine hydrochloride (ALLEGRA) and mentha x piperita oil (IBGARD); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0157) via an unspecified route of administration in the left arm on 13May2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Jun2021 at 10:00, the patient experienced instant and massive IBS attack 30 seconds after injection, bloating, discomfort and pain from gas pressure in stomach. All over the counter remedies had failed and weakness was constant in left arm at injection point. Daily and constant IBS attacks 24 hours a day, 7 days a week, previously attacks used to be every other week, or after misbehaving. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified medications and had a referral to a gastro specialist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event instant and massive IBS attack 30 seconds after injection, bloating, discomfort and pain from gas pressure in stomach and weakness was constant in left arm at injection point were not recovered at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: A rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Jul2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included autism. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jul2021, the patient experienced a rash about 3 x 3 and rounded below right shoulder which looked like shingles but did not hurt or itch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events a rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch were not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Major loss of smell; Major loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Feb2021(at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); both from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on an unknown date in 2021 at 02:00 as a single dose for COVID-19 immunisation. It was reported that the patient had no allergies to medications, food, or other products. On 27Feb2021 after 4 days, the patient experienced major loss of smell and taste. The patient had no improvement for the events till 12Jul2021. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events loss of smell and taste was not recovered at the time of this report.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Dyspnoea, Fatigue, Flushing, Gait inability
Clinical narrative: Got a metallic taste in the mouth; Flush; Felt sick; Muscle cramping; Severe fatigue; Aching; Not been able to walk more than a few blocks or exercise since; Flu-like symptoms; Not been able to walk more than a few blocks or exercise/muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down; Get out of breath; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 10:00 (at the age of 52-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 24Mar2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy to cephalosporin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. It was reported that the patient was in good health while receiving both the first and second doses of the vaccine. The patient was walking and jogging 6 miles a day. The minute the patient received the vaccines, she got a metallic taste in the mouth, flush and then felt sick for an hour. This went away both the times, however, the patient had muscle cramping and severe fatigue and aching since the first dose and had not been able to walk more than a few blocks or exercise since. It had now been 3.5 months of waiting for the flu-like symptoms to go away. The patient's muscles went into cramps doing small things like stairs or an incline on the street or even just house cleaning while getting up and down and the patient got out of breath. The patient had been to the doctor and could not find the cause. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste, flush and felt sick were resolved on an unknown date in 2021. The clinical outcome of the events muscle cramping, severe fatigue, aching, and not been able to walk more than a few blocks or exercise since, flu-like symptoms, muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down and get out of breath were not resolved at the time of this report.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Loss of personal independence in daily activities, Malaise, Muscle spasms, Pain
Clinical narrative: Got a metallic taste in the mouth; Flush; Felt sick; Muscle cramping; Severe fatigue; Aching; Not been able to walk more than a few blocks or exercise since; Flu-like symptoms; Not been able to walk more than a few blocks or exercise/muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down; Get out of breath; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 10:00 (at the age of 52-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 24Mar2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy to cephalosporin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. It was reported that the patient was in good health while receiving both the first and second doses of the vaccine. The patient was walking and jogging 6 miles a day. The minute the patient received the vaccines, she got a metallic taste in the mouth, flush and then felt sick for an hour. This went away both the times, however, the patient had muscle cramping and severe fatigue and aching since the first dose and had not been able to walk more than a few blocks or exercise since. It had now been 3.5 months of waiting for the flu-like symptoms to go away. The patient's muscles went into cramps doing small things like stairs or an incline on the street or even just house cleaning while getting up and down and the patient got out of breath. The patient had been to the doctor and could not find the cause. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste, flush and felt sick were resolved on an unknown date in 2021. The clinical outcome of the events muscle cramping, severe fatigue, aching, and not been able to walk more than a few blocks or exercise since, flu-like symptoms, muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down and get out of breath were not resolved at the time of this report.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Blisters on arm with shot, blisters on hip (same side), blisters on back; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 09:00 (at the age of 65-year-old), as a single dose and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 15Mar2021 at 13:15, the patient experienced blisters on arm with shot, then blisters on the hip (same side), and then blisters on the back. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with corticoid cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blisters on arm with shot, blisters on hip (same side), blisters on back was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site movement impairment, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm continues to be sore at the injection site and the surrounding area; Arm continues to be swollen at the injection site and the surrounding area; With some reduction in range of motion; Feeling tingling in feet, primarily left foot; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to gluten. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021, the patient arm continued to sore and swollen at the injection site and the surrounding area, with some reduction in her range of motion. The patient also reported that she felt tingling on her feet, primarily patient left foot where patient have never had that before, It was not debilitating but very annoying and not getting better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, swollen at the injection site, the surrounding area with some reduction in range of motion and felt tingling on feet, primarily left foot were not recovered at the time of this report.    The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Paraesthesia
Clinical narrative: Burning in both right and left feet; Tingling in both right,left feet and hands; Local burning sensation in thighs; Numbness in left little finger, 5th digit; This is a spontaneous report from a non contactable consumer, the patient. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EL9269) via an unspecified route of administration on an unknown date in Feb2020 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Feb2020 the patient experienced burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger was unknown at the time of this report.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 48-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Jul2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included brain hemorrhage that has resolved.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jul2021, on the day of vaccination, the patient experienced headache which did not go away. Therapeutic measures were taken as a result of headache and included treatment with unspecified medication started on an unknown date. The clinical outcome of the event headache was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: Hearing difference/difficulty; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Jul2021 at 13:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergies to medications, food, or other products which was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Multivitamins (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jul2021 at 23:00 the patient experienced hearing difference/difficulty. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hearing difference/difficulty was not resolved at the time of report.  The lot number for BNT162b2 was not provided and will be requested during follow up
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia
Clinical narrative: muscle and joint pain in knees and legs and ankle; muscle and joint pain in knees and legs and ankle; I had a fever with 2nd dose within 18 hrs after shot; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the right arm on 02Jul2021 at 10:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included type-2 diabetes mellitus which was borderline. The patient was allergic to latex and orange citric mixed with lemon. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the right arm on 11Jun2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Jul2021 at 04:30, within 18 hours after the second dose, the patient experienced fever. On 09Jul2021, after 7 days of the second dose, the patient experienced muscle and joint pain in her knees, legs and ankle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Tylenol 500mg, twice in 24 hours. The clinical outcome of the events muscle and joint pain in knees, legs and ankle and fever were resolving at the time of this report.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: a large lump where the vaccine was administered; This is a spontaneous report from a non-contactable nurse, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0168) via intramuscular route of administration in the left arm on 19May2021 at 10:00 (at the age of 56-years-old). The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021 at 10:00, the patient had a large lump where the vaccine was administered and two months later the lump was still there. The patient had no pain or discomfort but a noted lump. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a large lump where the vaccine was administered was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Gastrointestinal pain, Paraesthesia, Tremor
Clinical narrative: Tremors; Sharp shooting abdominal and intestinal pain; Sharp shooting abdominal and intestinal pain; Tingling; This is a spontaneous report from a non-contactable nurse, the patient. A 34-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced tremors, tingling sharp shooting abdominal and intestinal pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events tremors, tingling Sharp shooting abdominal and intestinal pain was recovering at this time of report.   No follow-up attempts are possible. No further information is expected